Search Results - "Gallego, Rebecca A."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Lipophilic Efficiency as an Important Metric in Drug Design by Johnson, Ted W, Gallego, Rebecca A, Edwards, Martin P

    Published in Journal of medicinal chemistry (09-08-2018)
    “…Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chemistry lead optimization programs. In…”
    Get full text
    Journal Article
  2. 2

    Reviving B‑Factors: Activating ALK Mutations Increase Protein Dynamics of the Unphosphorylated Kinase by Johnson, Ted W, Bolanos, Ben, Brooun, Alexei, Gallego, Rebecca A, Gehlhaar, Dan, Jalaie, Mehran, McTigue, Michele, Timofeevski, Sergei

    Published in ACS medicinal chemistry letters (13-09-2018)
    “…Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that can become oncogenic by activating mutations or overexpression. Full kinetic…”
    Get full text
    Journal Article
  3. 3

    An update on lipophilic efficiency as an important metric in drug design by Gallego, Rebecca A, Edwards, Martin P, Montgomery, T Patrick

    Published in Expert opinion on drug discovery (02-08-2024)
    “…Lipophilic efficiency (LipE) and lipophilic metabolic efficiency (LipMetE) are valuable tools that can be utilized as part of a multiparameter optimization…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Reviving B‑Factors: Retrospective Normalized B‑Factor Analysis of c‑ros Oncogene 1 Receptor Tyrosine Kinase and Anaplastic Lymphoma Kinase L1196M with Crizotinib and Lorlatinib by Johnson, Ted W, Gallego, Rebecca A, Brooun, Alexei, Gehlhaar, Dan, McTigue, Michele

    Published in ACS medicinal chemistry letters (13-09-2018)
    “…Structure-based drug design (SBDD) is commonly leveraged in rational drug design. Usually, ligand and binding site atomic coordinates from crystallographic…”
    Get full text
    Journal Article
  8. 8